Apelin in ST segment elevation and non-ST segment elevation acute coronary syndromes: a novel finding
Kahraman Cosansu, Huseyin Altug Cakmak, Baris Ikitimur
1Istanbul University, Cerrahpasa Medical Faculty, Department of Public Health. alpincan@yahoo.fr.
Apelin levels correlate differently with cardiac biomarkers in acute coronary syndromes (ACS). While positively associated in non-ST elevation ACS, apelin shows a negative correlation in ST-elevation myocardial infarction (STEMI) patients.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Apelin is an endogenous peptide with known inotropic and vasodilatory effects.
- Its role in acute coronary syndromes (ACS) requires further elucidation.
Purpose of the Study:
- To investigate apelin's prognostic role in ACS.
- To assess correlations between apelin and established diagnostic/prognostic markers.
Main Methods:
- Plasma apelin-36 levels were measured in 76 ACS patients (35 STEMI, 41 NSTE-ACS).
- Correlations with ejection fraction (EF), hsCRP, CK, CK-MB, and troponin I were analyzed.
- Patients were followed for one year for cardiovascular outcomes.
Main Results:
- No significant association found between apelin and TIMI, GRACE, GENSINI scores, hsCRP, or EF.
- Apelin positively correlated with CK, CK-MB, and troponin I in NSTE-ACS.
- Apelin negatively correlated with these biomarkers in STEMI patients.
Conclusions:
- Apelin exhibits differential correlations with cardiac biomarkers in STEMI versus NSTE-ACS.
- The observed negative correlation in STEMI may relate to the larger myocardial infarction size in these patients.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Angina III: Clinical Manifestations and Assessment


